Global Clinical Oncology Next Generation Sequencing Market Size, Forecasts, And Opportunities
Learn about the global clinical oncology next generation sequencing market through The Business Research Company, which provides information on clinical oncology next generation sequencing market size, clinical oncology next generation sequencing market drivers and restraints, clinical oncology next generation sequencing market players, the COVID-19 impact on the clinical oncology next generation sequencing market, and more.
The global clinical oncology next generation sequencing market size is expected to grow from $0.36 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 9.7%. The global clinical oncology NGS market size is expected to grow to $0.68 billion in 2026 at a CAGR of 14.7%.
The rise in the number of cancer cases across the globe is likely to contribute to the growth of the clinical oncology next-generation sequencing market during the forecast period.
Request A Sample For The Global Clinical Oncology Next Generation Sequencing Market Report:
The clinical oncology next-generation sequencing market consists of sales of devices and equipment used in clinical oncology next-generation sequencing and related services by entities (organizations, sole traders, and partnerships) that manufacture clinical oncology next-generation sequencing equipment. Next-generation sequencing is a process used to determine the sequence of nucleotides in a section of DNA and is used for oncology research. Only goods and services traded between entities or sold to end consumers are included.
Global Clinical Oncology Next Generation Sequencing Market Segments Include:
By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing
By Application: Screening, Companion Diagnostics, Others
By End-User: Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the clinical oncology next-generation sequencing market in 2021.
Companies in the clinical oncology next-generation sequencing are increasingly investing in automation of workflow to increase precision and reduce the sample to sample variability.
TBRC’s clinical oncology next generation sequencing market report covers:
Major Market Players: Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)
The Clinical Oncology Next Generation Sequencing Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides clinical oncology next generation sequencing market overviews, analyzes and forecasts market size, share, clinical oncology next generation sequencing market players, clinical oncology next generation sequencing market segments and geographies, leading competitor revenues, profiles and market shares.
TBRC’s clinical oncology next generation sequencing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports From The Business Research Company:
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_infao
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: